XML 67 R57.htm IDEA: XBRL DOCUMENT v3.19.2
Subsequent Events - Additional Information (Details) - Royalty Rights - Sanofi (Aventis Inc.) - Subsequent Event - USD ($)
$ in Millions
Jul. 18, 2019
Jul. 31, 2019
Subsequent Event [Line Items]    
Amount Payable to reacquire research and development asset $ 80.0 $ 80.0
Royalty expense 50.0  
Transferred to escrow 30.0  
MYK-491 Program    
Subsequent Event [Line Items]    
Research and development asset reacquired $ 4.3